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Abstract
Little is currently known about bacterial pathogen evolution and adaptation within the host during acute infection. Previous
studies of Burkholderia pseudomallei, the etiologic agent of melioidosis, have shown that this opportunistic pathogen
mutates rapidly both in vitro and in vivo at tandemly repeated loci, making this organism a relevant model for studying
short-term evolution. In the current study, B. pseudomallei isolates cultured from multiple body sites from four Thai patients
with disseminated melioidosis were subjected to fine-scale genotyping using multilocus variable-number tandem repeat
analysis (MLVA). In order to understand and model the in vivo variable-number tandem repeat (VNTR) mutational process,
we characterized the patterns and rates of mutations in vitro through parallel serial passage experiments of B. pseudomallei.
Despite the short period of infection, substantial divergence from the putative founder genotype was observed in all four
melioidosis cases. This study presents a paradigm for examining bacterial evolution over the short timescale of an acute
infection. Further studies are required to determine whether the mutational process leads to phenotypic alterations that
impact upon bacterial fitness in vivo. Our findings have important implications for future sampling strategies, since colonies
in a single clinical sample may be genetically heterogeneous, and organisms in a culture taken late in the infective process
may have undergone considerable genetic change compared with the founder inoculum.
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Introduction
In vivo studies of pathogen evolution have provided important
insights into the dynamic adaptability of infectious agents during
the course of an infection. To date, the overwhelming majority of
within-host evolution work has focused upon monitoring pathogen
adaptations concomitant with chronic infection establishment and
persistence. In particular, in vivo population dynamics of human
immunodeficiency-1 virus (HIV-1), the etiologic agent of acquired
immunodeficiency syndrome (AIDS), have been intensely charac-
terized (see [1–4] for salient examples). Due to their small genomes
and high level of mutability, RNA viruses have provided an
attractive avenue for investigating in vivo evolution of pathogen
populations. Recently, in vivo studies of pathogen evolution have
begun to shift towards bacterial infections. A hallmark study of in
vivo bacterial evolution during chronic infection compared whole-
genome sequences of two Pseudomonas aeruginosa strains derived
from a single cystic fibrosis patient. Isolated 90 months apart,
genetic changes conducive to niche adaptation and persistence
within the complex lung environment were demonstrated [5].
However, despite these landmark studies, none have examined
bacterial population diversity during an acute infection.
The Gram-negative bacterium Burkholderia pseudomallei is the
cause of melioidosis, a potentially life threatening disease
contracted through inhalation or direct inoculation of B.
pseudomallei from contaminated soil or water [6]. Clinical
manifestations and disease severity are highly variable. In its acute
form, patients with melioidosis often present with bacteremia
associated with bacterial dissemination, most often to the lung,
liver and spleen [7,8]. At over 7 Mbp and with two chromosomes,
B. pseudomallei possesses one of the largest bacterial genomes
characterized so far. Horizontal gene transfer, recombination and
mutation all play a role in shaping its genome [9] and contribute
to the impressive strain-to-strain variability observed in the pan-
genome of B. pseudomallei [10,11]. Within its genome are insertion
sequence elements [10,12], genomic island loci [11,13,14] and an
unusually high number of variable-number tandem repeats
(VNTRs) [10,15]. Several studies have demonstrated that B.
pseudomallei VNTRs can mutate over a short period of time. U’Ren
and co-workers [15] conducted an in vitro parallel serial passage
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large numbers of VNTR mutations upon short-term subculturing.
Likewise, ten in vivo B. pseudomallei isolates collected over a two-
week period from a single acute melioidosis patient were shown to
harbor differences at VNTR loci [16]. Taken together, B.
pseudomallei appears to possess the attributes required for rapid in
vivo mutation and therefore micro-evolution over the period of an
acute infection.
The aim of this study was to genetically characterize 182
primary agar plate colonies of B. pseudomallei isolated from multiple
body sites from four Thai patients with acute melioidosis over a
short period of time (two days to two weeks) using multilocus
variable-number tandem repeat (VNTR) analysis (MLVA). The
MLVA system targets 23 rapidly evolving repeat regions
throughout the B. pseudomallei genome [15]. While not appropriate
for examining more distant relationships due to its homoplastic
nature, MLVA is appropriate for detecting genetic relationships
amongst closely related isolates [16]. Our goals were two-fold; first,
to assess the level of within-host genetic variation at different body
sites and to examine whether genotyping could identify the
founder genotypes and suggest the primary site of clinical infection
and routes of dissemination based upon the MLVA patterns, and
second, to model in vivo mutations using observed in vitro VNTR
mutation rates and to make inferences about the spatial
distribution of B. pseudomallei in acute melioidosis infections.
Results
Genotyping of within-patient isolates
We applied pulsed-field gel electrophoresis (PFGE) to all 182
isolates obtained from the four patients to determine clonality of
infection. PFGE has previously been used to rule out re-infection
from a different B. pseudomallei strain or simultaneous infection with
multiple strains [17,18], and is commonly used to differentiate
closely related bacterial strains within outbreaks [19]. In the
current study, PFGE demonstrated that B. pseudomallei genotypes
were monomorphic within each patient (results not shown). While
this method did not provide high resolution within an infection,
the clonality of pulsotypes suggested that all isolates within
each patient arose from a single cell or population of clonal B.
pseudomallei. MLST of two primary colonies from each patient
supported the homogeneity of within-patient genotypes (STs 670,
208, 177 and 671 for patients 19, 23, 44 and 45, respectively). STs
670 and 671 were novel whereas STs 177 and 208 have been
identified previously in Thai melioidosis patients.
Unlike PFGE and MLST, the higher-resolution MLVA
technique discriminated among within-patient isolates. In addition
to confirming clonality of the four acute infections, MLVA
provided discrimination amongst the otherwise indistinguishable
isolates from within each patient, with VNTR mutants being
detected at multiple tissue sites. Due to the presence of multiple
disseminated small abscesses, P19 had the greatest number of
sampled tissue sites (n=7), primary colonies (n=65) and MLVA
genotypes (n=12). Between 37 and 40 primary colonies were
obtained from four tissue sites in the other three patients and a
total of eight, six and four MLVA genotypes were identified in
P45, P23 and P44, respectively (Figure 1).
In vitro mutation rates at VNTR loci
An in vitro parallel serial passage experiment (PSPE) for the
genome-sequenced Bp305 strain was undertaken in order to
quantify in vivo VNTR mutation patterns, and to add to our
knowledge of in vitro VNTR mutation rates in B. pseudomallei.A
summary of the in vitro 23-MLVA mutation rates for the Bp305
PSPE alone and in combination with a previous PSPE for Bp9905-
1902 is shown in Table 1. Thirty-one mutations were observed in
Bp305 at T10, compared with 12 mutations in Bp9905-1902 at
T10. In Bp9905-1902, an overwhelming number (95%) of these
mutations consisted of single-repeat changes with only a single T10
mutant characterized by a multi-repeat change [15]. Bp305, on
the other hand, demonstrated multi-repeat changes in approxi-
mately 40% of mutations, most of which occurred at locus 2170k
(Table 1). Bp9905-1902 mutated at eight of the 23 VNTR loci
whereas Bp305 only mutated at five, despite the inherent larger
number of generations in the Bp305 PSPE due to its longer
subculturing time (24 and 48h, respectively). This difference could
be attributable to the larger repeat copy numbers of the additional
mutating loci in Bp9905-1902 compared with Bp305, as has been
previously observed amongst Escherichia coli strains [20]. A high
number of PCR failures were evident in the T10 Bp305 clones for
the 20k (48%) and 2356k (33%) loci, as previously observed in
certain VNTR loci of Bp9905-1902 [15]; these failures are
probably a consequence of mutation at the primer binding sites or
recombination, resulting in an insertion or deletion that would
affect PCR efficiency. Given these high failure rates there is
reduced potential for discovering mutations at these loci.
Thirteen of the 23 MLVA loci did not mutate in either the
Bp305 or Bp9905-1902 PSPEs, three of which (3652k, 2445k and
1934k) had novel mutations in our in vivo patient isolates. For these
non-mutated loci, the limit of detection for the combined PSPE
data (2.4610
26 mutations/generation) was used to calculate the
probabilities of phylogenies for P19 and P45 (Figures S1 and S2),
since the likely mutation rate is near to or less than this rate. The
single-locus mutation rates in the combined Bp305 and Bp9905-
1902 in vitro dataset ranged from 2.17610
25 to 4.71610
24
mutations/generation, with an average mutation rate of
9.861.4610
25 mutations/generation (Table 1). This rate is
greater than the average VNTR mutation rate at 43 loci for Y.
pestis (6.360.09610
25 mutations/generation) [21,22] and the 28-
locus rate for E. coli O157:H7 (3.860.10610
25 mutations/
generation) [20]. This rate confirms previous reports demonstrat-
ing very high VNTR mutation rates in B. pseudomallei [15,16,23].
Author Summary
While both viral and bacterial pathogens have been shown
to undergo genetic changes over the course of a chronic
infection, this phenomenon has not been studiedduring an
acuteinfectionandas such isnot wellunderstood.Here,we
examined within-host evolution of the pathogen Burkhol-
deria pseudomallei during acute infection. B. pseudomallei
causes the disease melioidosis, a significant cause of
morbidity and mortality in many tropical regions of the
world. We obtained multiple B. pseudomallei colonies from
several tissue sites of four patients presenting with acute
melioidosis in order to characterize how this bacterium
evolves within the human host over a short period of time.
By monitoring changes in rapidly evolving genetic regions,
we found high levels of diversity of B. pseudomallei
populations within a single patient, and even within a
single body site. Comparison of these within-host mutation
rates with in vitro mutation data enabled us to identify the
most likelyspatial migrationof within-hostpopulationsand
correlate these findings with clinical data to determine, in
most cases, the origin of infection. Our study provides new
insights into the evolution of bacterial pathogens during an
acute infection, and lays the foundation for similar studies
in other infectious agents.
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We compared the patterns of in vitro and in vivo VNTR
mutations observed in the combined PSPEs and the four acute
melioidosis patients, respectively, with the patterns expected based
upon a theoretical model. Vogler and co-workers have proposed a
general VNTR mutation model describing the distribution of
VNTR mutations involving different numbers of repeats, and have
demonstrated its applicability for modeling VNTR mutation
patterns in E. coli and Y. pestis [20,22]. We used this model and an
observed frequency of 74.3% single-repeat mutations (comprising
both insertions and deletions) in our combined PSPEs to construct
a theoretical distribution of B. pseudomallei VNTR mutations
(Table 1; Figure 2). While the distribution predicted from this
model fitted well with the observed number of mutations
comprising one-, two-, three- and four-repeats in the combined
PSPEs, there were more observed mutations involving greater
than four repeats than expected based upon the theoretical model
(Figure 2); this circumstance has also been observed in a series of
E. coli O157:H7 PSPEs [20]. Several loci (2050k, 3152k, 2170k
and 1764k) had multi-repeat deletions in the Bp305 PSPE, with
2170k exhibiting an elevated number of multi-repeat deletions
compared with other loci, an expected finding given the large
number of repeats in Bp305 at this locus compared with Bp9905-
1902 (Table 1). A similar large VNTR locus (O157-10) in E. coli
O157:H7 PSPEs, which ranged from nine to 66 repeats,
contributed to elevated mutation rates in this species [20]. There
was a predominance of multi-repeat deletions over insertions in
our dataset, particularly at 2170k, although both are theoretically
equally likely; this trend was also observed in E. coli and has been
hypothesized to be a result of positive selection favoring deletions
in large arrays [20].
We characterized earlier time points for all Bp305 lineages
containing multi-repeat VNTR mutations using MLVA to identify
whether these mutations occurred as single or multiple mutation
events (Table S1). The mechanism behind multi-repeat VNTR
mutation events is important in determining the probability of the
mutation, as both slipped-strand mispairing and recombination
have been suggested as mechanisms of multi-repeat VNTR
Figure 1. Maximum parsimony phylogenies of Burkholderia pseudomallei isolates derived from four Thai acute melioidosis patients.
Phylogenies for patients 19, 23, 44 and 45 are shown in Panels A-D, respectively. Multiple tissue sites from each patient were cultured (e.g. blood,
urine, tracheal, wound and pus samples). Where possible, ten colonies from each tissue site were retrieved; isolates were genotyped using a 23-locus
multilocus variable-number tandem repeat analysis. In each patient, the numerically dominant genotype was assumed to be the original infecting
strain. Specific mutations are displayed alongside each branch (e.g. 3652k-1 refers to a one-repeat deletion at locus 3652k). A single, theoretical,
intermediate genotype not observed in our isolate set (Panel D, 20k+1 and 3152k-8) is represented by a solid black square. Asterisks indicate probable
founder genotypes. See Figures S1 and S2 for alternative P19 and P45 phylogenies and Table S2 for in vivo mutation rate calculations.
doi:10.1371/journal.ppat.1000725.g001
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these two mechanisms is considerably different [20,24]. Impor-
tantly, recombination events leading to multi-repeat mutations
cannot be modeled accurately using the geometric distribution
VNTR model, as this model assumes that only slipped-strand
mispairing causes VNTR mutations. By analyzing intermediate
generations (backtracking) using glycerol stocks from our Bp305
PSPEs, we were able to ascertain that all of the in vitro multi-repeat
deletions likely occurred in a single evolutionary step (Table S1)
and, as such, were most likely due to single recombination events
rather than large slipped-strand mispairing events. Removal of
2170k, the locus with the greatest number of multi-repeat
mutations, from the PSPE data yielded a mutation type
distribution that more closely mimicked the expected slipped-
strand distribution (results not shown). Due to the likely
involvement of recombination in generating multi-repeat muta-
tions greater than four repeats in vivo (i.e. the 3152k eight-repeat
mutation occurrences in P19 and P45) the probability of these
events are grossly underestimated by the geometric distribution
model (Figure 2). Nevertheless, we consider the geometric
distribution to be suitable for modeling in vivo mutations that
involve one, two, three or four repeat mutations in B. pseudomallei,
consistent with the E. coli O157:H7 PSPEs [20].
In vivo phylogenetic modeling
Maximum parsimony phylogenies for the within-host isolates
from each patient (Figure 1) were evaluated using a combination
of in vitro mutation rates (Table S2) and the geometric distribution
VNTR model. For P23 and P44, a single possible phylogeny was
constructed (Figure 1B and C), whereas multiple parsimonious
phylogenies were constructed for P19 and P45. Comparison of
alternative P45 phylogenies using the odds ratio approach
suggested that the phylogeny in Figure 1D was much more likely
than other phylogenies (ORs.150; Figure S2). In contrast, the
P19 phylogeny shown in Figure 1A was only slightly more likely
than alternative phylogenies (ORs,20), which were therefore
considered equally parsimonious (Figure S1).
Founder genotypes and subgroup founders
Identifying the founder genotype enables a better understanding
of in vivo spatial distribution of genotypes and potential routes of
infection. The founders were initially defined using eBURST, a
widely implemented algorithm that assesses divergence from a
Table 1. In vitro mutation rates for 23 Burkholderia pseudomallei multilocus variable-number tandem repeat analysis loci.
Locus
Repeat
motif
(bp)
Mutation rate
(Bp9905-1902
and Bp305
combined*)
Repeat
copy no.
(Bp305)
Mutation
rate
(Bp305)
Repeat
copy no.
(Bp9905-
1902)**
Mutation rate
(Bp9905-
1902)**
Bp305
total no.
mutations
Bp305
no.
lineages
Bp305
no.
insertions
Bp305
no.
deletions
Bp305
no.
single
repeat
changes
Bp305
no.
multi-
repeat
changes
2170k 9 4.71610
24 41 6.28610
24 13 2.28610
24 17 99 3 14 9 8
2050k 9 1.97610
24 18 2.93610
24 17 5.45610
25 8 100 3 5 6 2
3152k 6 1.31610
24 17 1.48610
24 24 1.06610
24 49 9 31 3 1
3145k 9 2.28610
25 3 --- 14 6.05610
25 0 100 --- --- --- ---
933k 12 3.66610
25 8 --- 14 5.51610
25 0 100 --- --- --- ---
1788k 16 2.20610
25 7 --- 9 5.45610
25 0 98 --- --- --- ---
2815k 9 2.17610
25 6 --- 30 5.28610
25 0 99 --- --- --- ---
20k 7 3.02610
25 12 --- 17 5.28610
25 0 52 --- --- --- ---
2065k 8 2.25610
25 11 3.93610
25 17 --- 1 93 1 0 1 0
1764k 12 2.20610
25 19 3.77610
25 10 --- 1 97 0 1 0 1
Average 9.7761.4610
25 1.9260.24610
24 1.5962.4610
24
Total --- g=9.77610
24 --- g=1.15 610
23 --- g=7.70610
24 31 --- 10 21 19 12
Percent --- --- --- --- --- --- --- --- 32.3 67.7 61.3 38.7
PSPE, parallel serial passage experiment.
*includes instances where one strain did not have any observed mutations for a given locus.
**data from [15] were rescored in the current study and edited accordingly.
doi:10.1371/journal.ppat.1000725.t001
Figure 2. Frequency distribution of Burkholderia pseudomallei
multilocus variable-number tandem repeat (VNTR) analysis
mutations. The predicted geometric distribution model (black) was
compared with in vitro (gray) and in vivo (white) VNTR mutation data.
The geometric distribution model fits well with observed mutations of
between one and four repeats; however, this model is not appropriate
for predicting 5+ repeat copy number mutations, as previously
observed in Escherichia coli O157:H7 [20].
doi:10.1371/journal.ppat.1000725.g002
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lates the founder as the genotype with the greatest number of
single-locus, and when identical, double-locus variants. In recently
diverged populations such as clonally derived in vivo populations,
the founder would also be expected to be numerically dominant.
We observed that the eBURST founders were both numerically
dominant and were disseminated to the greatest number of tissue
sites in P19, P23 and P45, with eBURST bootstrap values of 100,
97 and 94%, respectively (Figure 1A, 1B and 1D). In contrast,
eBURST analysis of P44 isolates did not identify the numerically
dominant and most spatially distributed genotype as the founder
genotype. Instead, eBURST assigned the 2445k+1 genotype (urine
and shoulder wound samples) as the founder due to this genotype
exhibiting the greatest number of single-locus variants (Figure 1C).
Unlike in the other patients, this P44 founder assignment was not
strongly supported by eBURST, with only 72% founder bootstrap
support. As the eBURST algorithm does not take into account
spatial distribution of genotypes, we assigned the genotype with
the greatest frequency and degree of spatial distribution as the P44
founder (Figure 1C). We assumed that the P44 2445k+1 genotype
was instead a subgroup founder (a clone that has diversified and
spawned its own clones) of the larger ‘founder’ population.
Comparison of clinical features and disease progression
with MLVA data
It was possible to pinpoint the probable site of the initial
infection in some of the patients based upon the tissue site
exhibiting the greatest degree of genetic diversification from the
founder genotype. For instance, the MLVA data indicate that the
probable primary site of initial infection in P44 and P45 are the
shoulder and calf wounds, respectively (Figure 1C and 1D),
consistent with clinical observations (Table 2). The primary site of
infection of P23 is more difficult to define as, according to the
MLVA data, both the anal and scrotal abscesses are likely, and
possibly simultaneous, candidates (Figure 1B). This observation is
in agreement with the clinical data, which indicated that this
patient had two weeks of progressive anal and scrotal abscesses
(Table 2).
Patient 19 developed disseminated melioidosis following a
motorcycle accident that resulted in a head injury, left thigh
wound and multiple abrasions. Clinically, the most likely site of
primary infection was the left thigh, which progressed to
necrotizing fasciitis (and was later positive for B. pseudomallei),
although entry of B. pseudomallei via the multiple abrasions and
inhalation cannot be excluded. Subsequent bacterial dissemination
after a period of around one week from the initial thigh wound
infection or an alternative, clinically covert focus was associated
with positive blood cultures, pneumonia and multiple subcutane-
ous abscesses. The MLVA profile for 65 colonies from seven
sampling sites demonstrated approximately equal levels of genetic
divergence from the founder genotype at multiple sites (Figure 1A
and Table 2).
Patients 23, 44 and 45 had similar clinical presentations, with a
history of an abscess as the primary site of infection followed by
bacterial dissemination to other sites in association with clinical
deterioration. Patient 23 presented with a two-week history of
perianal and scrotal abscesses, and had disseminated melioidosis
on admission with cultures positive from blood and urine in
addition to positive abscess cultures (Table 2). The MLVA data
based on a total of 40 colonies from four samples (Figure 1B)
indicated that the founder genotype was present and predomi-
nated in the two abscesses as well as in urine and blood, with
genetic diversification in all samples. Patient 44 presented with a
five-day history of an abscess at the left shoulder, followed by
subsequent bacterial dissemination. MLVA data based on a total
of 37 colonies from four samples (Figure 1C) indicated that the
putative subgroup founder (2445k+1) was present in the shoulder
abscess and urine, whereas the putative founder was identified in
the shoulder, blood and lungs. Patient 45 initially presented with
acute symptoms (fever and calf abscess) with defervescence five
days post-ceftazidime treatment. However, this patient experi-
enced relapse of fever accompanied by respiratory distress
approximately two weeks after the B. pseudomallei-positive pus
and blood specimens were collected, at which time the tracheal
suction isolates from P45 were obtained. These temporally distinct
tracheal suction isolates demonstrated the persistence of the
founder genotype over this two-week period (Figure 1D). In
addition to the founder genotype, a single 2050k+1 mutant was
identified in both the tracheal suction isolates and in the blood, but
not in the pus samples. These P45 results indicate the persistence
of the founder genotype andthe 2050k+1 genotype in the lungs.
However, greater numbers of isolates from several tissue sites,
including later samples from blood and calf abscess, would be
required to confirm this hypothesis.
Interestingly, the P44 founder genotype was not observed
among the urine-derived isolates, suggesting potential independent
spread of the subgroup founder from its point of origin (i.e. the
shoulder wound) to the renal system. A similar subgroup founder
in P45 (2170k+1) showed site-specific diversification of calf-derived
pus samples. Other potential subgroup founders were identified in
P19 (Figure 1A, 20k-1 and 1764k-1) and P45 (Figure 1D, 20k+1),
although only a single representative was observed. While no
subgroup founders were found in P23, the urine isolates were
mostly of a novel genotype, represented by a single repeat insertion
at 2050k, with only four of the ten urine isolates sharing the
founder genotype. Unlike the P44 urine-derived isolates, no other
tissue sites shared the dominant P23 urine genotype (Figure 1B,
2050k+1).
Discussion
Previous studies defining the proportion of patients with
melioidosis that are infected with more than one strain of B.
pseudomallei during a single infective episode have utilized PFGE or
ribotyping to characterize multiple B. pseudomallei colonies from the
same patient [17,26]. While these methods are useful for
identifying polyclonal infections, they cannot discriminate among
multiple colonies from patients infected with a single strain, as they
lack sufficient resolution. These methods are also not definitive
indicators of monoclonal infection, particularly if environmental
diversity is limited. In a recent study, MLVA was used to
characterize ten B. pseudomallei colonies from a single patient with
acute melioidosis [16]. The current study sought to expand on this
previous work by characterizing in vivo changes in VNTR loci
using 182 B. pseudomallei obtained from several body sites from four
patients with severe acute melioidosis. MLVA provided important
insights into the genetic heterogeneity of individual strains of B.
pseudomallei by offering fine-scale resolution unattainable using
MLST and PFGE, which, similarly to previous studies, were
unable to differentiate between within-patient colonies. Indeed,
even current next-generation whole genome sequencing (WGS)
technologies may prove unfruitful in achieving the resolution of
the 23-MLVA approach, due to inherently poor characterization
of repeat regions [27], in which much of the genetic variation
within this bacterial species is likely to be missed. Additionally, it is
currently impractical to perform WGS on such a large number of
isolates. As WGS becomes cheaper and more mature, it will be
capable of capturing both fine and large scale evolution and will
Within-Host Evolution of Burkholderia pseudomallei
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demonstrated that MLVA is a powerful method for defining
fine-scale epidemiological patterns over short-term in vivo passage.
The pathophysiology of melioidosis is poorly understood due to
the frequent lack of obvious inoculation site or recent trauma, the
broad and inconsistent nature of symptoms between individuals,
and the fact that almost any body site can become involved during
an infection [28,29]. Compounding this difficulty, differences in
disease characteristics are likely conferred by both host and
pathogen factors. As genetic plasticity is a hallmark of the B.
pseudomallei genome, one of our goals was to better understand the
extent to which the infecting isolate underwent genetic change in
vivo. In addition, we wanted to compare the genetic changes
identified by MLVA against detailed clinical features to determine
the ability for MLVA to predict the primary site of inoculation.
There was general concordance between clinical and genetic
approaches for three of the four melioidosis patients (P23, P44 and
P45), all of whom developed one or more clinically defined and
circumscribed abscesses prior to bacterial dissemination and
clinical deterioration. Dissemination of the founder genotype was
observed in these three patients, with genetic variants identified
both in the primary infection focus and in putatively seeded sites.
On the other hand, P19 had a more complex clinical history that
was suggestive of infection of a thigh wound inflicted during a
motorbike accident. While the thigh wound was the most plausible
primary focus, the clinical data were unable to exclude
simultaneous B. pseudomallei inoculation of numerous superficial
epidermal abrasions. By applying PFGE and MLST to the P19
isolates, it was demonstrated that multiple inoculation events were
unlikely given the monoclonal nature of the infection. Using
MLVA, we obtained approximately equal levels of divergence
from the founder genotype, and it was not possible to identify a
tissue site consistent with the primary site of infection. The MLVA
data for P19 suggested two hypotheses; firstly, that the founder
genotype present in the primary inoculation site (e.g. the thigh
wound) may have disseminated to numerous secondary sites prior
to subsequent genetic diversification. Alternatively, an inhalation
event may explain founder genotype dissemination to multiple
tissues. However, an inhalational route of exposure is inconsistent
with clinical progression in P19, as inhalational melioidosis in Thai
patients is commonly associated with fulminant pneumonia within
24 hours of exposure [30]. Therefore, the MLVA pattern and
clinical data for P19 are suggestive of dissemination of the founder
genotype following primary inoculation of a single focus (i.e. thigh
wound) of infection. The complexity of the MLVA pattern in this
patient may also be a function of the greater number of tissue sites,
and hence colonies, obtained from this patient. To resolve the
precise route of infection with MLVA, earlier isolates from
multiple tissue sites, especially from the necrotizing thigh wound,
would have been necessary. Taken together, these data demon-
strate that both clinical and genotype data can be used to
determine the site of primary infection, but also highlight the need
for even more intense sampling of tissue sites over multiple time
periods in complex clinical cases.
We observed an interesting pattern in the urine MLVA
genotypes derived from P23 and P44, which were predominantly
Table 2. Within-patient Thai Burkholderia pseudomallei isolates used in this study.
Patient
ID
Specimen
location
Collection
date
No.
colonies
Proportion
of founder
genotypes
Proposed site
of primary
infection* Clinical features and outcome
P19 Blood
Tracheal suction
Urine
Pustule, right leg
Pustule, left leg
Pustule, forehead
Wound swab, thigh
17-Jul-06
17-Jul-06
17-Jul-06
17-Jul-06
17-Jul-06
17-Jul-06
18-Jul-06
10
9
9
9
10
8
10
9/10
7/9
7/9
4/9
8/10
5/8
9/10 x
22 y.o. male, admitted after a motorcycle accident. Day 4
developed necrotizing fasciitis with abscess formation in a
left thigh wound from which Streptococcus pyogenes was
isolated. Blood culture on day 6 was positive for B.
pseudomallei (not available for this study). Samples shown
here were taken on day 11 & 12 when the patient had
disseminated melioidosis with bacteremia, multiple
cutaneous abscesses and pneumonia. The left thigh
wound was positive for B. pseudomallei at this stage.
Patient died from fulminant sepsis.
P23 Urine
Pus, right scrotal abscess
Pus, anal abscess
Blood
20-Jul-06
20-Jul-06
20-Jul-06
20-Jul-06
10
10
10
10
4/10
9/10
9/10
8/10
x
x
60 y.o. diabetic male rice farmer presented with 14 day
history of progressive perianal and scrotal abscesses.
Blood and abscess material obtained on day 1 was positive
for B. pseudomallei (not available for this study). Samples
shown here were taken on day 4 when the patient had
disseminated melioidosis. Patient died from fulminant
sepsis.
P44 Tracheal suction
Blood
Urine
Abscess, left shoulder
2-Aug-06
2-Aug-06
2-Aug-06
2-Aug-06
10
10
7
10
10/10
10/10
0/7
4/10 x
34 y.o. female rice farmer presented with a five-day history
of left shoulder abscess. Abscess pus taken on admission
was positive for B. pseudomallei. Samples shown here were
taken on day 3 when the patient had disseminated
melioidosis. Patient died from fulminant sepsis.
P45 Pus, calf (1)
a
Isolator (blood)
Pus, calf (2)
Tracheal suction
1-Aug-06
2-Aug-06
2-Aug-06
20-Aug-06
10
10
10
10
7/10
5/10
9/10
9/10
x 51 y.o. male rice farmer presented with 7 day history of
right calf abscess; two pus samples and blood culture were
positive for B. pseudomallei (samples shown). Pneumonia
developed on day 19 despite appropriate antimicrobial
therapy when a tracheal suction sample was positive for B.
pseudomallei (samples shown). Patient taken home by
family; outcome unknown.
*According to clinical data.
aIsolates collected from the same tissue site but at different times.
doi:10.1371/journal.ppat.1000725.t002
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out of ten urine isolates from P23 had a genotype that was not
observed in other tissues. Similarly, the seven urine isolates from
P44 comprised two genotypes, one of which was not found in
other tissues. It is unclear why the urine isolates were distinct from
the founder genotype in these patients. These urine-derived
genotypes may have migrated from unsampled organs and tissue
sites, or may indicate tissue compartmentalization (segregation) of
B. pseudomallei in the renal system. For example, the 2445k+1
genotype (urine and shoulder isolates) in P45 may have arisen
following transit of a shoulder wound isolate to the renal system via
the bloodstream. The possibility of independent growth in the
urinary tract system after segregation is supported by the lack of
correlation between counts of the organism in blood and urine
[31]. An alternative hypothesis for these segregated MLVA
profiles is that the infecting inoculum contained multiple
genotypes, and a secondary genotype was more fit for survival
in the kidneys; however, the identical PFGE patterns observed
for all isolates from P23 and P44 does not support this alternate
hypothesis. Therefore, the renal system may play a more
significant role in melioidosis pathogenesis than presently
appreciated. Unfortunately, due to the poor outcomes of the
acute melioidosis patients from this study, it was not possible to
collect temporal isolates from these three patients. Further studies
using greater numbers of temporal isolates from multiple tissue
sites are needed to test the compartmentalization hypothesis of
urine samples.
Patient 45 was the only patient in our study that afforded
temporal comparison of genotypes in vivo. Isolates from a
tracheal suction were collected two weeks after the initial isolates
were obtained, following the development of pneumonia despite
antimicrobial therapy. The MLVA results indicated that the
tracheal isolates mostly harbored the founder genotype, but also
shared a second genotype with blood isolates collected two weeks
earlier, suggesting not only persistence of the founder genotype
throughout the course of the infection but the possibility of
seeding of B. pseudomallei into the lungs (via the bloodstream)
from an unsampled tissue site. Potential tissue compartmental-
ization was also observed in P45, where calf abscess samples
appeared to segregate from blood and tracheal samples
(Figure 1D). As in P23, we did not find evidence for multiple
genotypes in the infecting inoculum, which is based upon our
observation of identical PFGE profiles from all P45 isolates. This
segregation of MLVA genotypes was an unexpected finding that
suggests potential independent evolution of the calf abscess
isolates and the contribution of an auxiliary, unsampled tissue
site (e.g. the spleen) to bloodborne, and ultimately lung,
diversity.
In order to understand in vivo mutation rates and patterns, we
undertook an in vitro mutation experiment of Bp305 and
combined these data with a previous PSPE on Bp9905-1902
[15]. While one-, two- three- and four-repeat mutations
appeared to fit well with a general VNTR mutation model
[20], the likely contribution of recombination in generating B.
pseudomallei VNTR mutations comprising five or greater repeats
rendered itdifficulttoaccurately model multi-repeatmutations in
vitro and in vivo. This difficulty is exemplified by estimates of the
number of generations required to attain the eight-repeat
deletion at locus 3152k, a mutation observed in vivo in both P19
and P45. According to the general VNTR mutation model and
our in vitro B. pseudomallei VNTR mutation rates, the 3152k-8
event would be expected to occur every 1.4610
8 generations
(95% confidence interval: 3.5610
6 to 7.4610
8 generations;
Table S2); however, given the short time scale of infection, this
number of generations is not biologically possible. As such, it is
tempting to speculate that the in vivo mutation rate is potentially
much greater than witnessed in vitro; however, the involvement of
recombination events occurring at unknown rates, as well as
three subculturing events prior to in vivo isolate characterization,
complicates any such conclusions. While we were unable to
directly compare the relative rates of in vitro and in vivo mutation
due to the use of different strains from the patients and in the
PSPEs, future PSPEs on the in vivo isolates could shed light on
potential locus-based differences in these strains and may more
accurately model the in vivo mutation events described in this
study. The combined PSPE data will prove useful in future in vivo
evolution studies of B. pseudomallei, such as for determining in vivo
generation times in temporally-related isolates.
The 23-MLVA markers, which are predominantly intergenic
and thus presumably selectively neutral, represent only a fraction
of the loci that contribute to B. pseudomallei diversity. VNTRs not
used in our 23-MLVA scheme, including those in coding regions
or VNTRs that affect transcription, are important for under-
standing bacterial fitness in different niches within the human host.
Analysis of other genetic markers encoding virulence factors,
antimicrobial resistance, or genes involved in enhanced invasion,
evasion and mutability would shed insights into pathogen
adaptability under immune and drug pressures and could be
observed using WGS. For instance, horizontal gene transfer within
genomic islands that encode proteins involved in virulence, tissue
tropism, and persistence probably influence ecological establish-
ment and clinical outcome [11,13,14]. Sam et al. [32] recently
demonstrated heterogeneity in antibiotic susceptibilities of a small
number of isolates from a single patient. Our large collection of in
vivo isolates provides an opportunity to expand on the Sam et al.
study and build upon our current limited knowledge in this field of
melioidosis research. Other avenues of investigation using an in
vivo evolution approach include examining the bacterial factors
behind chronic persistence of melioidosis, or the involvement of
co-infections, such as the group A Streptococcus co-infection
observed in P19, in generating genetic diversity in B. pseudomallei
during acute and chronic melioidosis.
It is recognized that there are potential criticisms of our
approach. Firstly, only a maximum of ten colonies per tissue
site were obtained, resulting in sampling bias towards more
dominant genotypes and potentially overlooking minor geno-
types within samples. Secondly, there are known differences in
B. pseudomallei growth rates and population size between different
anatomical sites. We sampled essentially identical numbers of
colonies from each anatomical site and did not take into account
the inherently higher genetic variation at a high bacterial load
(e.g. respiratory secretion and pus) versus a low bacterial load
site (e.g. blood) [33]. Such differences in replication rates may
have an impact on the prediction of the founder genotype. While
we used eBURST principles to predict the founder (i.e. the most
numerically dominant genotype with the greatest number of
single-locus variants), more detailed analyses are required
to verify these founder assignments, such as animal model
studies or phylogenetic outgroup rooting with a closely related
environmental isolate. Thirdly, the identification of anatomical
sites with low prevalence of the founder genotype, such as
observed in the P23 and P44 urine sites, could feasibly arise by
chance. Unfortunately, we were unable to apply meaningful
confidence intervals to our small dataset to determine whether
the low prevalence of founder genotypes in the urine-derived
isolates from P23 and P44 were significant, and therefore we
cannot rule out stochastic factors contributing to these
observations. Lastly, many samples were taken several days
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PLoS Pathogens | www.plospathogens.org 7 January 2010 | Volume 6 | Issue 1 | e1000725after onset of symptoms and sampling time points were not
consistent across the patient group. Despite these shortcomings,
this study is the first of its kind to explore acute infection in such
depth and many of these issues were not known at the
commencement of the study. Based upon our observations, we
recommend that future work in this field should attempt to
reduce the effects of genotype bias by using greater numbers of
isolates from a single tissue site, including larger numbers of
study patients, and aiming for the collection of temporal isolates
f r o mt h es a m et i s s u es i t e / s ,i no r d e rt om o r er i g o r o u s l yt e s tin vivo
pathogen evolution hypotheses.
In conclusion, the current study is the first to employ fine-scale
genotyping on a comprehensive in vivo isolate collection derived
from acute infections. Given the remarkable genetic diversity of B.
pseudomallei within a single tissue site at a single time point, this
investigation highlights the rapid genetic modification and
potential for adaptability of B. pseudomallei to niches within the
human host. The ability for B. pseudomallei to diversify over a short
time frame has substantial implications for our understanding of
treatment, eradication and prevention of melioidosis. Our findings
are not only of interest to melioidosis researchers, but will likely
have major impact in the food safety, clinical and microbial
forensic communities. For example, the use of limited numbers of
reference strains in an epidemiological context should be
questioned in light of our study. We recommend that sampling
and genetic characterization of several isolates from both the
source and the host, or carrier, becomes the standard for such
investigations in order to account for inevitable evolutionary
processes.
Methods
Ethics statement
Informed written consent has previously been obtained from
each subject enrolled into the study [17].
Study subjects and specimen processing
The four study subjects with acute melioidosis described herein
(patients 19, 23, 44 and 45) represent a subset of patients recruited
into a prospective study that defined rates of polyclonal B.
pseudomallei infection. Patients were admitted between June and
August 2006 to a hospital in Ubon Ratchathani, northeast
Thailand [17]. In brief, patients with suspected melioidosis were
sought during twice-daily ward rounds of the medical and
intensive care wards and multiple samples were taken from
suspected cases. A 15mL blood sample was taken and divided
between a BacT/ALERTH FA bottle (BioMe ´rieux, Durham, NC)
for standard culture (5mL), and an Isolator 10 lysis centrifugation
tube (Oxoid, Basingstoke, Hampshire, UK) (10mL). Samples were
taken for culture of sputum/tracheal aspirate, throat swab, urine,
pus or surface swab from wounds and skin lesions as appropriate.
The objective of our culture techniques was to achieve single B.
pseudomallei colonies on primary agar plates that had been directly
inoculated with the clinical sample [17]. Briefly, clinical specimens
were spread-plated onto Ashdown agar [34]. Colonies suspected
to be B. pseudomallei were tested using an oxidase test and
subsequently confirmed with a B. pseudomallei-specific latex
agglutination test [17]. Ten primary plate colonies were picked
from each sample positive for B. pseudomallei and saved to
independent freezer vials; all colonies were picked if fewer than
ten were present. Each colony was stored at 280uC and sub-
cultured a total of three times prior to DNA extraction for MLVA.
The four patients were selected from patients with four or more
samples positive for B. pseudomallei. The number of primary
colonies per patient ranged from 37 to 65, and the total number
tested was 182. The clinical history of the four cases is summarized
in Table 2. All four patients had disseminated melioidosis. Three
patients died in hospital, and the fourth was seriously ill when
taken home by relatives and his outcome is unknown.
DNA isolation
Genomic DNA (gDNA) was extracted from clinical B.
pseudomallei isolates propagated on Luria-Bertani agar (Becton
Dickinson, Franklin Lakes, NJ) for 48 h at 37uC using the
DNeasy
TM 96 Tissue Kit (Qiagen Inc., Valencia, CA) according to
the manufacturer’s protocol. A 5% chelex-100 (BioRad, Hercules,
CA) extraction protocol [35] was used to isolate gDNA from B.
pseudomallei 305 (Bp305) PSPE isolates (see ‘In vitro mutation rates
of VNTRs in B. pseudomallei’ below for isolate descriptions).
Qiagen-extracted gDNA was quantified fluorimetrically (Spectra-
Max Gemini; Molecular Devices, Sunnyvale, CA) and diluted to
500 pg/mL in molecular grade H2O (Invitrogen, Carlsbad, CA);
chelex-extracted gDNA was diluted 1:9 in molecular grade H2O.
Genotyping
Multilocus sequence typing (MLST) was undertaken on two
primary colonies from each of the four patients. MLST was
performed according to Godoy et al. [36]. To improve amplifica-
tion robustness for the gmhD locus, we used modified amplification
primers [18]. New sequence types (STs) were submitted to the B.
pseudomallei MLST database (http://bpseudomallei.mlst.net/).
Pulsed-field gel electrophoresis was performed on all 182 primary
plate colonies, as previously described [18].
MLVA based on 23 predominantly intergenic, and hence
presumed to be selectively neutral, VNTR loci was performed on
all colonies as previously detailed [15,23], with the exception of an
increase in betaine (Sigma-Aldrich, St Louis, MO) concentration
in the multiplex PCRs from 1.2 to 2.0M. Briefly, MLVA involved
multiplexed PCR amplification of VNTR regions using differen-
tially labeled fluorescent primers. Following amplification, the
PCR products were diluted 1:25 in molecular grade H2O,
denatured in HiDi
TM formamide (Applied Biosystems, Foster
City, CA) and subjected to capillary electrophoresis using a 3730xl
DNA Analyzer (Applied Biosystems). Size determination was
carried out relative to an internal LIZ1200H ladder (Applied
Biosystems) and GeneMapper version 4 software (Applied
Biosystems) was used for peak analysis [15,16]. All data were
independently double-scored by two researchers.
In vitro mutation rates of VNTRs in B. pseudomallei
A ,27,000 generation parallel serial passage experiment
(PSPE) was carried out to determine in vitro mutation rates
for the 23 VNTR loci used in the MLVA. Such estimates can
be used to facilitate phylogenetic analyses of isolates cycling
in vivo [22]. While a PSPE has been carried out on B.
pseudomallei Bp9905-1902 [15] we sought to provide a more robust
estimate of VNTR mutation rates for B. pseudomallei by adding
another isolate to the PSPE dataset. The genome-sequenced
Bp305 (GenBank: AAYX00000000; http://www.ncbi.nlm.nih.
gov/nuccore/AAYX00000000) was selected for this purpose.
One whole colony of Bp305 T0 (timepoint zero) was
resuspended in 1 mL trypticase soy broth (TSB; Becton Dickinson)
and 100 separate loopfuls were used for subculture onto 100 new
trypticase soy agar (TSA) plates (T1) to establish 100 independent
lineages. All Bp305 lineages were incubated at 37uC for 48 hours;
in contrast, the PSPE lineages from Bp9905-1902 were subcul-
tured at 24 h intervals. The difference in culture time between the
two isolates was taken into account in all mutation rate estimates.
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was subcultured on TSA to create T2 and incubated as described
above. This process was iterated eight additional times until T10
was reached. The half-colonies not used for subculture were
suspended in 1X TSB with 20% sterile glycerol and stored at
280uC to facilitate backtracking of mutation occurrence. DNA
was extracted (as described in ‘DNA isolation’ above) from the
original T0 suspension and all one hundred T10 isolates, and
genotyped with MLVA. In instances where VNTR mutants were
identified at T10 (i.e. VNTR sizes from T10 did not match data
from T0), isolates from earlier timepoints of the corresponding
lineage were subcultured and characterized by MLVA to ascertain
whether the mutation was the result of a single- or multi-step
mutation event (Table S1).
To calculate the number of generations in a 48 h colony, a
randomly chosen T0 colony was subjected to a tenfold serial
dilution, ranging from 10
21 to 10
28. One hundred microliters of
each dilution was plated onto TSA and incubated for 48 h prior to
colony counting. Based on these counts, approximately 1.69610
8
cells were present in one 48 h Bp305 colony, corresponding to
27.3 generations per 48 h colony, assuming each colony arose
from a single cell. To determine per-locus mutation rates, the
observed mutations at each locus for both Bp305 (this study) and
Bp9905-1902 [15] were divided by the total number of
generations for each isolate.
Construction of phylogenies
For our study, a maximum parsimony method was chosen
over other phylogenetic modeling methods (distance, maximum
likelihood and Bayesian analysis) as maximum parsimony assumes
a minimum number of mutational steps in estimating the
evolutionary history, making it appropriate for modeling simple
datasets such as clonally related in vivo populations [37]. The
program eBURST v3 (http://eburst.mlst.net/) is a parsimony-
based method that is widely used to determine the genetic
relatedness of bacterial populations that have diverged over short
evolutionary time spans based upon MLST data [25]. However,
eBURST analysis is not limited to MLST and can be used with
other datasets, such as MLVA data, when examining closely
related isolates. Therefore, we used the ‘population snapshot’
feature of eBURST to identify founder genotypes and to define the
population structure in the four in vivo within-host populations.
eBURST predicts the founder genotype as the genotype with the
greatest number of single-locus variants (and, where necessary,
double-locus variants); often, the founder genotype is also
numerically dominant [25].
Once the founder genotypes and population structure for the
patients were determined using eBURST, we applied the general
VNTR mutation model proposed by Vogler and co-workers
[20,22] to quantify the probability of mutations observed within
both eBURST-derived and alternative maximally parsimonious
phylogenies. The two B. pseudomallei PSPEs were used to
determine mutation rates at loci mutated in vivo. In instances of
multi-repeat mutations, the probabilities of single versus step-
wise mutation events were compared using respective in vitro
mutation rates. The products of the probabilities of each
mutational event for all parsimonious phylogenies were deter-
mined, and the likelihood of each phylogenetic scenario was
compared with an odds ratio, allowing the most likely phylogeny
to be compared to eachalternative phylogeny [22,38]. For each
patient, the most likely phylogeny is presented; refer to Figures
S1 and S2 for alternative phylogenies for P19 and P45,
respectively.
Supporting Information
Figure S1 Comparison of alternative in vivo Burkholderia pseudo-
mallei population phylogenies for P19. Using in vitro variable-
number tandem repeat (VNTR) mutation rates (Figure 2 and
Table S2) to model the probability of in vivo mutations, phylogeny
A was found to be more likely than alternative phylogenies B, C
and D. However, the odds ratios for the alternative phylogenies
were small, between 3.87 and 15, so we considered these four
phylogenies to be approximately equally parsimonious. Although
it has the highest odds ratio, phylogeny D best reflects patterns of
in vivo evolution in this patient according to mutational
backtracking. In addition, phylogeny D does not relate the
1764k-1 and 1764k-2 or 20k-1 and 20k-2 genotypes, consistent
with these genotypes occurring independently at different tissue
sites. Asterisks indicate the founder genotype; colors and circle
sizes are described in Figure 1.
Found at: doi:10.1371/journal.ppat.1000725.s001 (0.41 MB
DOC)
Figure S2 Comparison of alternative in vivo Burkholderia pseudo-
mallei population phylogenies for P45. Unlike in P19 (Figure S1),
alternative phylogenies for P45 contain differences in the number
of character-state changes and thus were constructed without tree
length restriction. In panels B and C, 2050k-3 was modeled as
multi-step mutations, allowing a greater number of permissible
character state changes compared with phylogeny A. Using in vitro
variable-number tandem repeat (VNTR) mutation rates (Figure 2
and Table S2) to model the probability of all in vivo mutations,
phylogeny A was found to be more likely than the alternative
phylogenies (panels B and C), with odds ratios for the alternative
phylogenies of 176 and 3,110,404, respectively. Consistent with
this ranking, phylogeny A most accurately reflects the in vivo
evolution as theoretical, intermediate genotypes (represented by a
solid black square) from phylogenies B and C were not observed in
our isolate set. Multi-step mutants of 3152k-8 were not modeled in
P45 due to the highly unlikely possibility of multi-step mutations
contributing to this mutation state (see Table 1 and Figure 2 for
further explanation), which was in concordance with mutational
backtracking that showed this mutation most probably occurred in
a single step. Asterisks indicate the founder genotype; colors and
circle sizes are described in Figure 1.
Found at: doi:10.1371/journal.ppat.1000725.s002 (0.32 MB
DOC)
Table S1 Mutational backtracking of Burkholderia pseudomallei
strain 305 (Bp305) lineages from a parallel serial passage
experiment. One hundred Bp305 lineages were examined at
timepoint 10 (T10) using multilocus variable-number tandem
repeat analysis (MLVA). Thirty lineages possessed MLVA mutants
at T10. In these lineages, Bp305 from previous timepoints were
characterized by MLVA to identify the timepoint and mechanism
of mutation (i.e. single-step or multi-step). Fields marked with ‘---’
represent data points that were not analyzed by MLVA. *DNA
extractions and MLVA typing for timepoints T0 and T10 were
conducted at the time of passage. For timepoints T1-T9, an
additional subculture was carried out prior to MLVA genotyping.
These genotypes could represent mutations that occurred
following this additional passage step.
Found at: doi:10.1371/journal.ppat.1000725.s003 (0.55 MB
DOC)
Table S2 In vivo variable-number tandem repeat (VNTR)
mutations observed in the four melioidosis patients, their
probabilities of occurrence and the theoretical number of
generations for observing those mutations.
aCalculated using
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distribution of VNTR mutation types: P(X=n)=p(1-p)n-1 [20]
where p is the probability of a single-repeat mutation based upon
observed data (74.3%), n is the number of repeats involved in the
mutation, and P is the relative probability of a mutation involving
n number of repeats.
bm, observed probability of a given mutation
at a specific locus.
cCI (confidence interval), calculated based upon
Poisson distribution, describes the upper and lower generations
required to observe a given mutation with 95% confidence
[20,22].
Found at: doi:10.1371/journal.ppat.1000725.s004 (0.04 MB
DOC)
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